Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Review(5)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(2)
Fisiología humana(2)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(5)
Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications
ReviewAbstract: Electroconvulsive therapy (ECT) is based on conducting an electrical current through the brain to stPalabras claves:electroconvulsive therapy, hippocampus, mood disorders, neurogenesis, neuroinflammatory diseases, neurotransmitter agents, refractory depression, SchizophreniaAutores:Ariza D., Bautista M.J., Chávez-Castillo M., Medina-Ortiz O., Ortega A., Pérez J.L., Riaño-Garzón M.E., Rojas M., Rojas-Quintero J., Torres L.C., Valmore BermúdezFuentes:scopusRole of endocrine-disrupting chemicals in the pathogenesis of non-alcoholic fatty liver disease: A comprehensive review
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disorder, affecting arPalabras claves:Endocrine-disrupting chemicals, Environmental pollutants, Exposure, Liver disorder, Non-alcoholic fatty liver diseaseAutores:Cano G., Cano R.A., Dávila L.C.A., Diaz M.P., Gomez Y., González M.C., Manzano A., Ortega A., Parra H., Pérez J.L., Rojas-Quintero J., Valero-Cedeño N.J., Valmore Bermúdez, Veliz T.Fuentes:scopusPsycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
ReviewAbstract: The placebo effect can be defined as the improvement of symptoms in a patient after the administratiPalabras claves:Analgesia, Cannabinoids, Conditioning, Depression, hormones, Opioid, Pain, Parkinson’s Disease, placebo effect, PsychoneuroimmunologyAutores:Ariza D., Chávez-Castillo M., Díaz-Camargo E.A., Galbán N., Medina-Ortiz O., Nava M., Ortega A., Riaño-Garzón M.E., Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusSpecialized pro-resolving lipid mediators: The future of chronic pain therapy?
ReviewAbstract: Chronic pain (CP) is a severe clinical entity with devastating physical and emotional con-sequencesPalabras claves:Central nervous system sensitization, Chronic pain, Eicosanoids, inflammation, Long-term poten-tiation, Nociception, Omega 3 fatty acids, pain management, Polyunsaturated fatty acids, Specialized pro-resolving lipid mediatorsAutores:Chávez-Castillo M., de Sanctis J.B., Durán P., Garrido B., Manzano A., Ortega A., Rojas M., Rojas-Gómez D.M., Salazar-Vílchez J., Silva A., Torres L.C., Valmore BermúdezFuentes:scopusThe yap/taz signaling pathway in the tumor microenvironment and carcinogenesis: Current knowledge and therapeutic promises
ReviewAbstract: The yes-associated protein (YAP) and the transcriptional coactivator with PDZ-binding motif (TAZ) arPalabras claves:Carcinogenesis, cell proliferation, Chemoresistance, Drug resistance, Hippo signaling pathway, immunotherapy, Neoplastic stem cells, TEAD, tumor microenvironment, YAP/TAZAutores:de Sanctis J.B., Diaz M.P., Navarro C., Ortega A., Parra H., Rojas M., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Vera I.Fuentes:scopus